Bionomics Investor Presentation Deck

[] Stock, Financial and IP Snapshot iii ✓Lean operations with modest burn ✓ Well-capitalized through CY2023 ✓ A$40.4M (US$29.2M) of net cash ✓ Listed on two global exchanges ✓ Leading Significant Investors: APEIRON BVF INVESTMENT GROUP PRESIGHT Bionomics Figures as of March 30, 2022. PARTNERS L.P. MERCK ASX: BNO AUSTRALIAN SICUS LACHE Nasdaq: BNOX ✓ Research Coverage: BERENBERG PRIVATBANKIERS SEIT 1590 EVERCORE William Blair CANTOR Pitzgerald X HCW H.C.WAINWRIGHT&CO. ✓ CNS patents filed in the US and abroad ✓USA: 4 granted, 5 pending ✓ Worldwide: 4 granted, 5 pending ✓ BNC210 freedom to operate opinion 14

View entire presentation